Duloxetine Capsule, Delayed Release Pellets
Product Images NDC 72162-1597
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Duloxetine (NDC 72162-1597). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Duloxetine 02)
Figure 2 (Duloxetine 03)
Figure 3 (Duloxetine 04)
Figure 4 (Duloxetine 05)
Figure 5 (Duloxetine 06)
Figure 6 (Duloxetine 07)
Figure 7 (Duloxetine 08)
Figure 8 (Duloxetine 09)
Figure 9 (Duloxetine 10)
Figure 10 (Duloxetine 11)
Label (Lbl721621597)
Description: This is a description of a medication called Duloxetine Hydrochloride, USP. Each capsule contains 22.4 mg of the active ingredient. The medication is in the form of delayed-release capsules. The National Drug Code (NDC) for this medication is 72162-1597-9. It is important to keep this medication out of the reach of children. The recommended storage temperature is 25°C (77°F) with excursions permitted between 15° to 30°C (59° to 86°F). The medication should be dispensed in a tightly closed container and is available only with a prescription. It is recommended to provide a Medication Guide to each patient. For more information, you can visit the website provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.